New Zealand’s Gene Technology Bill Faces Continued Delays

Prime Minister Christopher Luxon has clarified that the delays in progressing the Gene Technology Bill are not due to the coalition partner New Zealand First. Instead, he emphasized that the government is committed to thoroughly addressing the complexities of this important legislation. Originally scheduled for a report from Parliament’s health committee on July 31, the timeline has since been postponed to October 10.

The proposed legislation seeks to ease New Zealand’s long-standing restrictions on gene technology, aiming to lift a 30-year ban on its use outside laboratory environments. The initiative includes establishing a dedicated regulator under the Environmental Protection Authority to oversee gene technology applications. National Party representatives argue that New Zealand is lagging behind countries such as Australia, Canada, and the United Kingdom, all of which have embraced these technologies.

During the bill’s introduction in December 2022, then-science minister Judith Collins assured the public that this change would not lead to unrestricted use of genetic technologies. She stated, “This change simply means that gene technologies have a pathway to regulatory assessment that is designed to ensure the public and environmental safety of New Zealand.” Collins stressed that the new regulations would provide a structured approval method for those wishing to utilize these technologies.

In the initial debate, Mark Patterson, a member of New Zealand First, highlighted the need for careful consideration regarding the bill’s implications. He noted, “We must not trade away our GE-free competitive advantage lightly,” emphasizing the importance of feedback from the food export sector and organic producers. Patterson reiterated that it is essential to understand the potential risks and rewards involved in this legislative shift.

The complexities of the bill have prompted some members of the coalition to voice concerns. Shane Jones, acting for current science minister Dr. Shane Reti, described the legislation as a “work in progress.” In a recent inquiry, Winston Peters, leader of New Zealand First, responded to questions about the delays, indicating that the party is engaged in thorough discussions regarding the bill’s provisions.

Opposition parties, including Labour, the Greens, and Te Pāti Māori, have expressed their opposition to the legislation, highlighting the necessity for unanimous support from all coalition partners for the bill to advance. Labour’s science spokesperson Reuben Davidson raised concerns about potential disagreements within the coalition, suggesting that there is a lack of clarity on how to proceed with the bill.

Davidson stated, “There isn’t a pathway within the coalition to support the bill. It would seem that behind closed doors there’s disagreement, bickering, and a lack of clarity on a direction to move forward.” He criticized the bill for moving too quickly without fully addressing important implications for trade and public safety.

Despite these challenges, Prime Minister Luxon remains optimistic about the bill’s future. He asserted that the government is committed to ensuring that the legislation is carefully crafted. “We’re just taking a bit more time through the select committee process to make sure we get that drafted in the right way,” he said. Luxon underscored the importance of modernizing New Zealand’s legislative framework to keep pace with advancements in the 21st century.

As discussions continue, the fate of the Gene Technology Bill hangs in the balance, with significant implications for New Zealand’s approach to genetic engineering and its status within the global biotechnology landscape.